C. Onal Et Al. , "Stereotactic body radiotherapy for oligoprogressive lesions in metastatic castration-resistant prostate cancer patients during abiraterone/enzalutamide treatment.," The Prostate , vol.81, pp.543-552, 2021
Onal, C. Et Al. 2021. Stereotactic body radiotherapy for oligoprogressive lesions in metastatic castration-resistant prostate cancer patients during abiraterone/enzalutamide treatment.. The Prostate , vol.81 , 543-552.
Onal, C., Kose, F., Ozyigit, G., Aksoy, S., Oymak, E., Muallaoglu, S., ... Guler, O. C.(2021). Stereotactic body radiotherapy for oligoprogressive lesions in metastatic castration-resistant prostate cancer patients during abiraterone/enzalutamide treatment.. The Prostate , vol.81, 543-552.
Onal, Cem Et Al. "Stereotactic body radiotherapy for oligoprogressive lesions in metastatic castration-resistant prostate cancer patients during abiraterone/enzalutamide treatment.," The Prostate , vol.81, 543-552, 2021
Onal, Cem Et Al. "Stereotactic body radiotherapy for oligoprogressive lesions in metastatic castration-resistant prostate cancer patients during abiraterone/enzalutamide treatment.." The Prostate , vol.81, pp.543-552, 2021
Onal, C. Et Al. (2021) . "Stereotactic body radiotherapy for oligoprogressive lesions in metastatic castration-resistant prostate cancer patients during abiraterone/enzalutamide treatment.." The Prostate , vol.81, pp.543-552.
@article{article, author={Cem Onal Et Al. }, title={Stereotactic body radiotherapy for oligoprogressive lesions in metastatic castration-resistant prostate cancer patients during abiraterone/enzalutamide treatment.}, journal={The Prostate}, year=2021, pages={543-552} }